sulfamethoxazole has been researched along with HIV in 5 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis in HIV-uninfected, exposed (HUE) children variably reduces clinical malaria burden despite antifolate resistance, but data regarding achieved serum levels and adherence are lacking." | 7.88 | Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children. ( Anok, A; Duffy, PE; Eastman, RT; Gabriel, EE; Hobbs, CV; Kasule, J; Neal, J; Newell, K; Penzak, S; Reynolds, SJ; Serwadda, D, 2018) |
| "Hypersensitivity adverse drug reactions are much more common among patients with acquired immunodeficiency syndrome (AIDS) than in the general population." | 5.33 | Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. ( Dekaban, GA; Rieder, MJ; Wijsman, JA, 2005) |
| "Trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis in HIV-uninfected, exposed (HUE) children variably reduces clinical malaria burden despite antifolate resistance, but data regarding achieved serum levels and adherence are lacking." | 3.88 | Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children. ( Anok, A; Duffy, PE; Eastman, RT; Gabriel, EE; Hobbs, CV; Kasule, J; Neal, J; Newell, K; Penzak, S; Reynolds, SJ; Serwadda, D, 2018) |
| "Hypersensitivity adverse drug reactions are much more common among patients with acquired immunodeficiency syndrome (AIDS) than in the general population." | 1.33 | Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. ( Dekaban, GA; Rieder, MJ; Wijsman, JA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Washino, T | 1 |
| Mikita, K | 1 |
| Kosaka, A | 1 |
| Sakamoto, N | 1 |
| Iwabuchi, S | 1 |
| Nakamura-Uchiyama, F | 1 |
| Kasule, J | 1 |
| Gabriel, EE | 1 |
| Anok, A | 1 |
| Neal, J | 1 |
| Eastman, RT | 1 |
| Penzak, S | 1 |
| Newell, K | 1 |
| Serwadda, D | 1 |
| Duffy, PE | 1 |
| Reynolds, SJ | 1 |
| Hobbs, CV | 1 |
| Wei, KC | 1 |
| Sy, C | 1 |
| Wu, SY | 1 |
| Chuang, TJ | 1 |
| Huang, WC | 1 |
| Lai, PC | 1 |
| Wijsman, JA | 1 |
| Dekaban, GA | 1 |
| Rieder, MJ | 1 |
| Blossom, DB | 1 |
| Namayanja-Kaye, G | 1 |
| Nankya-Mutyoba, J | 1 |
| Mukasa, JB | 1 |
| Bakka, H | 1 |
| Rwambuya, S | 1 |
| Windau, A | 1 |
| Bajaksouzian, S | 1 |
| Walker, CJ | 1 |
| Joloba, ML | 1 |
| Kityo, C | 1 |
| Mugyenyi, P | 1 |
| Whalen, CC | 1 |
| Jacobs, MR | 1 |
| Salata, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Trimethoprim-sulfamethoxazole Prophylaxis on Malaria Infection and Immunity in Children in Uganda[NCT02094508] | 173 participants (Actual) | Observational | 2014-03-07 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sulfamethoxazole and HIV
| Article | Year |
|---|---|
Disseminated Toxoplasmosis associated with Haemophagocytic Lymphohistiocytosis in a Patient with the Human Immunodeficiency Virus: A Case Report and Literature Review.
Topics: Adult; Clindamycin; Female; HIV; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Sulfam | 2022 |
4 other studies available for sulfamethoxazole and HIV
| Article | Year |
|---|---|
Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children.
Topics: Anti-Retroviral Agents; Antimalarials; Drug Resistance; Female; Folic Acid Antagonists; HIV; HIV Inf | 2018 |
Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamid | 2018 |
Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
Topics: Animals; Anti-Infective Agents; Biotransformation; Cell Line; Cell Survival; Clindamycin; Coculture | 2005 |
Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.
Topics: Adult; Ambulatory Care Facilities; Anti-Infective Agents; Carrier State; Cross-Sectional Studies; Dr | 2006 |